HCPLive

Atherosclerosis

Latest Headlines

Tocilizumab Reduces LDL-C in Patients with Rheumatoid Arthritis
LDL-C was reduced in RA patients who took tocilizumab compared to placebo in a study published in Annals of the Rheumatic Diseases.
Tofacitinib Can Improve Cardiovascular Health in Rheumatoid Arthritis Patients
Rheumatoid arthritis patients have increased cardiovascular morbidity and mortality, but tofacitinib can reduce these issues, according to research published in Arthritis & Rheumatology.
Insulin Resistance Higher in Rheumatoid Arthritis Patients
The increased insulin resistance seen in rheumatoid arthritis (RA) patients compared to non-RA controls did not contribute to additional atherosclerosis risk, according to research published in Arthritis & Rheumatology.
Obesity Week 2014
Obesity Week 2014 was the second annual combined meeting of The Obesity Society (TOS) and the American Society for Metabolic & Bariatric Surgery (ASMBS).

Most Popular

$vacMongoViewPlus$ $vAR$